Stock ALZN ALZAMEND NEURO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Alzamend Neuro, Inc.

Equities

ALZN

US02262M4078

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
0.6336 USD -2.37% Intraday chart for Alzamend Neuro, Inc. +16.64% -28.81%
05-09 Alzamend Neuro, Inc. announced that it expects to receive $25 million in funding CI
03-25 Alzamend Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ALZAMEND NEURO, INC. Stock Alzamend Neuro, Inc.
 4.36M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 50.93B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.12B
LONZA GROUP AG Stock Lonza Group AG
 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.02B
  1. Stock Market
  2. Equities
  3. ALZN Stock
  4. Charts Alzamend Neuro, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW